谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 535 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
2 Oral: Preliminary Results from SEACRAFT-1: an Open-Label Study of Naporafenib with Trametinib in Patients with Locally Advanced Unresectable or Metastatic Solid Tumor Malignancies with RAS Q61X Mutations
E. Fontana,A.I. Spira, M. McKean, J. Lee, N. Chau, E. Winquist, I. Kim, S.H. Hong,B.A. Van Tine, A. Fawole, R. Shoemaker, Y. Cui, R. Sutton, J.M. Antal, S.R. Morris, D.S. Hong
European Journal of Cancer (2024)
引用0浏览0引用
0
0
1070Tip A Phase Ia/Ib Dose-Escalation/expansion Study of NPX887 in Subjects with Solid Tumor Malignancies Known to Express HHLA2/B7-H7
H. Cheng, I.I. Rodriguez Rivera, D.F. McDermott,A.I. Spira,Y. Ged, J. Liu, Y. Ji, M. Rausch, Y. Hashambhoy-Ramsay, K. Kis-Toth,L. Gandhi, A. Naing
Annals of Oncology (2024)
引用0浏览0引用
0
0
1394Tip KRYSTAL-7: A Phase III Study of First-Line Adagrasib Plus Pembrolizumab Versus Pembrolizumab Alone in Patients with Advanced NSCLC with KRASG12C Mutation
M.C. Garassino, P.A. Jänne, F. Barlesi,A.I. Spira, T.S.K. Mok,M. Hochmair, K.J. O'Byrne, E. Felip,S-W. Kim, F. Cappuzzo, J. Naidoo, M. Safadi, B. Wamil, J. He, M. Reck
Annals of Oncology (2024)
引用0浏览0引用
0
0
1 Oral: First Clinical Results from A Phase 1 Trial of PRT3789, a First-in-Class Intravenous SMARCA2 Degrader, in Patients with Advanced Solid Tumors with a SMARCA4 Mutation
T.A. Yap, A. Dowlati, I. Dagogo-Jack, J. Vibert,A.I. Spira,V. Moreno Garcia, S.R. Punekar, E. Calvo,G.P. Sonpavde, M. Awad,J.W. Riess,T. Hernández-Guerrero, B. Herzberg, A. Italiano, A. Swalduz, P. LoRusso, E.F. Smit, E.B. Garon, W. Novotny, R. Guo
European Journal of Cancer（2024）
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 541

#Citation: 17178

H-Index: 50

G-Index: 127

Sociability: 8

Diversity: 2

Activity: 430

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn